hengrui glp 1 Kailera Therapeutics Announces Positive Topline Data from Two Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535 Investors put $400M into biotech
Pay in 4 interest-free payments of $5.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19























